• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

A novel therapeutic strategy for ALS with induction of differentiation to M2 microglia by targeted gene delivery

Research Project

Project/Area Number 18K07498
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Review Section Basic Section 52020:Neurology-related
Research InstitutionShiga University of Medical Science

Principal Investigator

Terashima Tomoya  滋賀医科大学, 医学部, 准教授 (40378485)

Project Period (FY) 2018-04-01 – 2021-03-31
Project Status Completed (Fiscal Year 2020)
Budget Amount *help
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2020: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2019: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2018: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
Keywords筋萎縮性側索硬化症 / ミクログリア / 標的化輸送 / 核酸医薬 / miRNA / ドラッグデリバリーシステム / Molecular ZIP code / ドラックデリバリーシステム / 標的化 / 遺伝子輸送
Outline of Final Research Achievements

There is no established treatment for amyotrophic lateral sclerosis, and the development of its treatment is desired as an urgent issue. Therefore, we tried to establish an inducible method of neuroprotective type microglia from pro-inflammatory type by pinpoint gene delivery using the targeted peptides as a new treatment, because microglia are deeply involved in the progression of the disease. In primary cultured microglia, we succeeded in specific labeling of inflammation-inducing microglia and targeted transport of miRNA by gene transport using targeted MG1, and confirmed the miRNA effect on cell phenotype. In addition, administration of the microglial target peptide + miRNA complex to ALS model animals was shown to suppress the progression of pathological conditions and improve the survival curve.

Academic Significance and Societal Importance of the Research Achievements

筋萎縮性側索硬化症は難治性疾患であり、今回の新規治療法開発は、今後の臨床応用を期待させる大変社会的意義の高い研究成果であると言える。また、標的化ペプチドを用いて核酸を輸送することで、内因性の炎症惹起型のミクログリア細胞を神経保護型に誘導する戦略は、外部からの移植を用いる細胞治療やウイルスベクターを用いた遺伝子治療に比べ、免疫反応を最小限に抑えることができ、安全性が高く、他のミクログリア細胞が関与する神経疾患に対する治療への汎用性もあることから、多くの疾患治療研究の礎となる可能性もあり、学術的意義も非常に高いと考える。

Report

(4 results)
  • 2020 Annual Research Report   Final Research Report ( PDF )
  • 2019 Research-status Report
  • 2018 Research-status Report
  • Research Products

    (27 results)

All 2021 2020 2019 2018 Other

All Journal Article (8 results) (of which Int'l Joint Research: 2 results,  Peer Reviewed: 8 results,  Open Access: 7 results) Presentation (17 results) (of which Int'l Joint Research: 3 results,  Invited: 1 results) Remarks (2 results)

  • [Journal Article] Enhancing the Therapeutic Efficacy of Bone Marrow-Derived Mononuclear Cells with Growth Factor-Expressing Mesenchymal Stem Cells for ALS in Mice2020

    • Author(s)
      Terashima Tomoya、Kobashi Shuhei、Watanabe Yasuhiro、Nakanishi Mami、Honda Naoto、Katagi Miwako、Ohashi Natsuko、Kojima Hideto
    • Journal Title

      iScience

      Volume: 23 Issue: 11 Pages: 101764-101764

    • DOI

      10.1016/j.isci.2020.101764

    • NAID

      120006949252

    • Related Report
      2020 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Transplantation of M2-deviated microglia promotes recovery of motor function after spinal cord injury in mice.2020

    • Author(s)
      Kobashi S, Terashima T, Miwako Katagi, Yuki Nakae, Junko Okano, Yoshihisa Suzuki, Makoto Urushitani, Hideto Kojima.
    • Journal Title

      Molecular Therapy

      Volume: 28 Issue: 1 Pages: 254-265

    • DOI

      10.1016/j.ymthe.2019.09.004

    • Related Report
      2019 Research-status Report
    • Peer Reviewed
  • [Journal Article] Bone marrow-derived mononuclear cells relieve neuropathic pain after spinal nerve injury in mice2020

    • Author(s)
      Hiroshi Takamura, Tomoya Terashima, Kanji Mori, Miwako Katagi, Junko Okano, Yoshihisa Suzuki, Shinji Imai, and Hideto Kojima
    • Journal Title

      Molecular Therapy - Methods & Clinical Development

      Volume: 17 Pages: 657-665

    • DOI

      10.1016/j.omtm.2020.03.020

    • Related Report
      2019 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Advanced technology for gene delivery with homing peptides to spinal cord through systemic circulation in mice.2019

    • Author(s)
      Terashima T, Ogawa N, Sato T, Katagi M, Nakae Y, Okano J, Maegawa H, Kojima H.
    • Journal Title

      Mol Ther Methods Clin Dev

      Volume: 13 Pages: 474-483

    • DOI

      10.1016/j.omtm.2019.04.008

    • Related Report
      2019 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Efficient Prostate Cancer Therapy with Tissue-Specific Homing Peptides Identified by Advanced Phage Display Technology2019

    • Author(s)
      Wada Akinori、Terashima Tomoya、Kageyama Susumu、Yoshida Tetsuya、Narita Mitsuhiro、Kawauchi Akihiro、Kojima Hideto
    • Journal Title

      Molecular Therapy - Oncolytics

      Volume: 12 Pages: 138-146

    • DOI

      10.1016/j.omto.2019.01.001

    • Related Report
      2018 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Stem cell factor induces polarization of microglia to the neuroprotective phenotype in?vitro2018

    • Author(s)
      Terashima Tomoya、Nakae Yuki、Katagi Miwako、Okano Junko、Suzuki Yoshihisa、Kojima Hideto
    • Journal Title

      Heliyon

      Volume: 4 Issue: 10 Pages: 837-56

    • DOI

      10.1016/j.heliyon.2018.e00837

    • Related Report
      2018 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Gene therapy for neuropathic pain using dorsal root ganglion?targeted helper-dependent adenoviral vectors with GAD67 expression2018

    • Author(s)
      Ogawa Nobuhiro、Terashima Tomoya、Oka Kazuhiro、Chan Lawrence、Kojima Hideto
    • Journal Title

      PAIN Reports

      Volume: 3 Issue: 6 Pages: e695-e695

    • DOI

      10.1097/pr9.0000000000000695

    • Related Report
      2018 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Gene Therapy for Neropathic Pain through siRNA-IRF5 Gene Delivery with Homing Peptides to Microglia2018

    • Author(s)
      Terashima T, Ogawa N, Nakae Y, Sato M, Katagi M, Okano J, Maegawa H, Kojima H
    • Journal Title

      Molecular Therapy-Nucleic Acids

      Volume: 11 Pages: 203-215

    • DOI

      10.1016/j.omtn.2018.02.007

    • Related Report
      2018 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Presentation] GLT-1発現骨髄由来細胞によるALSへの新規治療法の開発2021

    • Author(s)
      寺島智也、大橋夏子、樫美和子、栄山真紀、中江由希、岡野純子、 鈴木義久、小島秀人
    • Organizer
      第20回日本再生医療学会総会
    • Related Report
      2020 Annual Research Report
  • [Presentation] 体内臓器再生を目指すヒト化ゼブラフィッシュモデルの確立2021

    • Author(s)
      大橋夏子、加藤史紘、樫美和子、中江由希、寺島智也、向英里、小島秀人
    • Organizer
      第20回日本再生医療学会総会
    • Related Report
      2020 Annual Research Report
  • [Presentation] 骨髄細胞を標的とした糖尿病の完治を目指した治療法の開発2021

    • Author(s)
      樫美和子、寺島智也、大橋夏子、中江由希、栄山真紀、岡野純子、鈴木義久、小島秀人
    • Organizer
      第20回日本再生医療学会総会
    • Related Report
      2020 Annual Research Report
  • [Presentation] 糖尿病末梢神経障害~診断と治療 update~ 先端技術を駆使した糖尿病末梢神経障害に対する次世代型治療への展望2020

    • Author(s)
      寺島智也
    • Organizer
      第35回日本糖尿病合併症学会総会 シンポジウム
    • Related Report
      2020 Annual Research Report
    • Invited
  • [Presentation] IL-4 誘導ミクログリア細胞移植による脊髄損傷への治療戦略2020

    • Author(s)
      寺島智也, 小橋修平, 樫美和子, 中江由希, 岡野純子, 大橋夏子, 鈴木義久, 小島秀人
    • Organizer
      第19回日本再生医療学会総会 Webのみ
    • Related Report
      2019 Research-status Report
  • [Presentation] 高血糖は造血幹細胞に病的記憶を残す2020

    • Author(s)
      小島秀人、樫美和子、大橋夏子、寺島智也、岡野純子、中江由希、鈴木義久
    • Organizer
      第19回日本再生医療学会総会 Webのみ
    • Related Report
      2019 Research-status Report
  • [Presentation] Combined bone marrow transplantation therapy of MNCs and growth factor expressing-MSCs for amyotrophic lateral sclerosis.2019

    • Author(s)
      Terashima T, Kobashi S, Watanabe Y, Nakanishi M, Honda N, Katagi M, Nakae Y, Ohashi N, Urushitani M, Kojima H.
    • Organizer
      The 30th Annual Meeting of the International Symposium on ALS/MND.
    • Related Report
      2019 Research-status Report
    • Int'l Joint Research
  • [Presentation] Transplantation therapy of bone marrow-derived M2 microglia-like cells on ALS model mice.2019

    • Author(s)
      Kobashi S, Terashima T, Katagi M, Nakae Y, Kojima H, Urushitani M.
    • Organizer
      第60回日本神経学会学術大会
    • Related Report
      2019 Research-status Report
  • [Presentation] 骨髄由来細胞の遊走性および標的化を応用した神経疾患への分子治療戦略2019

    • Author(s)
      寺島智也
    • Organizer
      第92回日本薬理学会年会 シンポジウム
    • Related Report
      2018 Research-status Report
  • [Presentation] 骨髄単核球および神経栄養因子群発現骨髄間葉系幹細胞併用骨髄移植による筋萎縮性側索硬化症への治療戦略2019

    • Author(s)
      寺島智也、小橋修平、渡辺保裕、中西真実、樫美和子、中江由希、岡野純子、鈴木義久、小島秀人
    • Organizer
      第18回日本再生医療学会総会
    • Related Report
      2018 Research-status Report
  • [Presentation] 細胞シート状態で大脳へ移植した間葉系幹細胞の生着に関与する因子の検討2019

    • Author(s)
      渡辺保裕、本多直人、中西真実、足立麻由香、寺島智也、花島律子
    • Organizer
      第18回日本再生医療学会総会
    • Related Report
      2018 Research-status Report
  • [Presentation] 実験的脳損傷モデルマウス作成の試み2019

    • Author(s)
      阪井田哲、寺島智也、樫美和子、中江由希、岡野純子、鈴木義久、小島秀人
    • Organizer
      第18回日本再生医療学会総会
    • Related Report
      2018 Research-status Report
  • [Presentation] 糖尿病性神経障害の完治に向けた新規治療標的の同定2019

    • Author(s)
      樫美和子、寺島智也、中江由希、岡野純子、鈴木義久、小島秀人
    • Organizer
      第18回日本再生医療学会総会
    • Related Report
      2018 Research-status Report
  • [Presentation] 糖尿病性神経障害は神経細胞に細胞融合を仕掛ける造血幹細胞疾患である2019

    • Author(s)
      小島秀人、樫美和子、寺島智也、岡野純子、中江由希、鈴木義久
    • Organizer
      第18回日本再生医療学会総会
    • Related Report
      2018 Research-status Report
  • [Presentation] A novel strategy for gene therapy for neuropathic pain through siRNA-IRF5 with homing peptides to microglia.2018

    • Author(s)
      Terashima T, Ogawa N, Nakae Y, Sato T, Katagi M, Okano J, Maegawa H, Kojima H.
    • Organizer
      The 21st Annual Meeting of the American Society of Gene & Cell Therapy.
    • Related Report
      2018 Research-status Report
    • Int'l Joint Research
  • [Presentation] Development of an effective technology for inductive differentiation from bone marrow-derived mononuclear cells to neuroprotective microglia.2018

    • Author(s)
      Kobashi S, Terashima T, Nakae Y, Katagi M, Kojima H, Urushitani M.
    • Organizer
      The 21st Annual Meeting of the American Society of Gene & Cell Therapy.
    • Related Report
      2018 Research-status Report
    • Int'l Joint Research
  • [Presentation] Gene therapy for neuropathic pain through siRNA delivery with homing peptides to microglia.2018

    • Author(s)
      Terashima T, Ogawa N, Nakae Y, Katagi M, Okano J, Kojima H.
    • Organizer
      第59回日本神経学会学術大会
    • Related Report
      2018 Research-status Report
  • [Remarks] 滋賀医科大学 生化学分子生物学講座 再生修復医学部門

    • URL

      https://www.shufuku.net/

    • Related Report
      2020 Annual Research Report 2019 Research-status Report
  • [Remarks] 滋賀医科大学 生化学・分子生物学講座 再生修復医学部門

    • URL

      https://www.shufuku.net/

    • Related Report
      2018 Research-status Report

URL: 

Published: 2018-04-23   Modified: 2022-01-27  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi